Development of a conceptual model for evaluating new non-curative and curative therapies for sickle cell disease is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: OT3HL152448
National Heart, Lung, and Blood Institute
Grant: OT3HL151434
NICHD NIH HHS
Grant: P2C HD042828
National Institutes of Health
Grant: 1OT3HL152448-01
Model for Economic Analysis of Sickle cell cURE (MEASURE)
National Institutes of Health
Grant: 6OT3HL151434-02
The Cure Sickle Cell Initiative Economic Analysis: An Evaluation of the Costs of Sickle Cell Disease and Potential Health Plan Budget Impacts of Gene Therapy as a New Treatment Option
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals